Type 2 diabetes

Specialist nurse Nicola Milne discusses the side effects that can arise in people with type 2 diabetes during initiation of GLP-1 receptor agonists, and how to best manage them.

Read our quick round-up of the LEAD trials of the daily injectable GLP-1 receptor agonist liraglutide in people with type 2 diabetes.

Read our quick round-up of the GetGoal trials of the daily injectable GLP-1 receptor agonist lixisenatide in people with type 2 diabetes.

Sanjay Kalra considers the course of action when blood glucose remains high in someone who cannot, or will not, modify a high-carbohydrate diet.

Lori Berard highlights the contribution of stress to poor glycemic control and considers how healthcare providers can account for this in their practice.

Sanjay Kalra explains why it is so important for healthcare professionals anywhere in the world to understand about Ramadan and the ramifications for people with diabetes.

Shehla Shaikh shares her experience and offers practical advice to help people with type 2 diabetes safely navigate the fasting and feasting of Ramadan. 

Julian Hamilton-Shield explains why weight loss is the key to type 2 diabetes management in children (2:04).

We round up the medications currently approved for treating type 2 diabetes in children and adolescents and look at what agents are coming through clinical trials.

Why and how does ethnicity influence risk and management approach for pediatric type 2 diabetes? We talk to childhood obesity specialist Julian Hamilton-Shield.

Torsten Olbers puts the case for metabolic surgery as a treatment option for children with type 2 diabetes.

Phil Zeitler discusses the pathophysiology of type 2 diabetes in children, and why it is so resistant to conventional management (2:58). 

AG Unnikrishnan highlights the problem of underdiagnosis of type 2 diabetes in children, and explains who to prioritize for screening (2:14).

Read this Hot Topic Review to catch up on the latest research into the risks and benefits of fasting for people with diabetes.

In this addition to our hyperglycemia series, Anthonia Ogbera makes the case for exercise as an underemployed care strategy and offers advice for achieving success.

Read our quick round-up of the DURATION trials of the weekly formulation of the GLP-1 receptor agonist exenatide in people with type 2 diabetes.

Read our quick round-up of the AWARD trials of the GLP-1 receptor agonist dulaglutide in people with type 2 diabetes.

John Wilding highlights the issue of hyperglycemia triggered by use of high-dose steroids and discusses management strategies.

Sanjay Kalra explains how use of alpha-glucosidase inhibitors in people with type 2 diabetes can complicate the treatment of hypoglycemia.